Title
|
Company Name
|
Platform / Modality
|
Target
|
Investor/Partner Relations
|
| Active Dry Powder Inhaler |
Oriel Therapeutics Inc |
Other(Device for delivering therapeutics to the lung) |
|
Strategic Partner |
| Aminoflavone Prodrug (AFP464) - A Novel Approach to Cancer |
Tigris Pharmaceutical, Inc. |
Small Molecules |
Treatment of MCF-7 human breast cancer cells with AF resulted in translocation of arylhydrocarbon receptor (AhR; a transcriptional regulator of CYP1A1) from the cytoplasm to the nucleus and subsequent interaction with xenobiotic-responsive element (XRE) sequence on the CYP1A1 promoter region to form AhR-XRE protein DNA complexes |
Licensing |
| Autologous Bone Marrow Adult Stem Therapy (ABMAS) |
BioArray Technologies, Inc. |
Biologic |
Damaged Heart Muscle Tissue after Heart Attack |
VC, Licensing, Strategic Partner |
| Blood-brain Barrier Delivery of Protein Therapeutics |
ArmaGen Technologies, Inc. |
Biologic |
Blood-Brain Barrier Drug Delivery |
Strategic Partner |
| Direct Cellular Energy Delivery System |
VitaTech and Novera, LLC |
Biologic |
hypoxic cells, tissues, and organs |
Licensing, Strategic Partner |
| PancAtak™ |
Advantagene, Inc. |
Biologic |
Patient-specific vaccine from non-patient-specific product |
Strategic Partner |
| Unique Analgesics for Neuropathic Pain |
St. Charles Pharmaceuticals |
Small Molecules |
|
VC, Licensing, Strategic Partner |